Combating the symptoms of menopause
The good news is that women today can reasonably expect to live into
their 90s. The bad news is that women today can reasonably expect to
live to be in their 90s. Bad news, that is, without some help along
the way to deal with the stresses, strains, and realities of growing
older.
For women in their 40s and 50s, the onset of menopause can be a troubling
time. Many women go through it without a lot of problems. For others,
however, menopause can be an awful experience. Menopause is that time
in mid-life when hormone levels begin to decrease and the menses cease.
What sometimes accompanies this change are hot flashes, night sweats,
and mood swings. There is also the concern of bone loss, caused in part
by a lack of estrogen, one of the hormones linked to the menstrual cycle.
Estrogen and progesterone have an active role in the menstrual cycle.
When their production is not in balance due to changes in the ovaries
and glands that produce the hormones, too much of one or the other may
be produced. What generally results is referred to as estrogen dominance;
that is, too much estrogen compared to progesterone.
AIM RevitaFem® a natural, botanical supplement that, combined with
regular exercise, management of stress, a whole foods diet, and elimination
of toxins, combats the symptoms of menopause. AIM RevitaFem® contains
eight botanical ingredients, all contributing unique properties to help
control excess estrogen and assist in regulating and balancing body
systems. In general, a natural ingredient in the product, called phytoestrogens,
modulates and helps regulate out-of-balance estrogen levels.
AIM RevitaFem® is a natural alternative
to hormone replacement therapy (HRT), which emerged in the 1960s to
treat the symptoms of menopause as well as a number of other conditions
including depression, cardiovascular disease, and bone loss. While HRT
was found to be effective, research has found a number of health concerns
that accompany it including blood clots, stroke, coronary heart disease,
and breast cancer.
|